Startup Secures $7.1M to Revolutionize Diagnostics with Liquid Biopsy Tech
-
This seems like a really interesting and promising technology!
trialsitenews.com
Israeli Startup Senseera Secures $7.1M to Revolutionize Diagnostics with Liquid Biopsy Technology
Jerusalem-based biotech startup Senseera has secured $7.1 million in seed funding from Lightspeed Venture Partners, Lowy Medical Research Institute, and I-Next Capital. Senseera’s innovative GEM BIOMARKERS™ liquid biopsy platform leverages cfChIP-seq technology to decode cell-specific gene expression and cell states from … Continue reading
Log in to reply.